Page 5,634«..1020..5,6335,6345,6355,636..5,6405,650..»

Toxic metal levels linked to autism

Posted: Published on March 1st, 2013

Published: Feb. 28, 2013 at 12:25 PM PHOENIX, Feb. 28 (UPI) -- Children with autism had higher levels of several heavy metals in their blood and urine compared to typical children, U.S. researchers reported. Study leader James Adams, who directs the Arizona State University Autism/Asperger's Research Program, said the study involved 55 children with autism ages 5-16 compared to 44 controls of similar age and gender. The study, published in the journal Biological Trace Element Research, found the autism group had significantly higher levels -- 41 percent -- of lead in their red blood cells and 74 percent higher urinary levels of lead, 77 percent higher levels of thallium, 115 percent higher levels of tin and 44 percent higher levels of tungsten. Lead, thallium, tin and tungsten are toxic metals that can impair brain development and function, and also interfere with the normal functioning of other body organs and systems, Adams said. A statistical analysis was conducted to determine if the levels of toxic metals were associated with autism severity, using three different scales of autism severity. The study found 38 percent to 47 percent of the variation of autism severity was associated with the level of several toxic metals, … Continue reading

Comments Off on Toxic metal levels linked to autism

Insurance commissioner wants autism law enforced

Posted: Published on March 1st, 2013

SACRAMENTO, Calif. (AP) - California's insurance regulator has been getting complaints and wants last year's autism treatment law enforced. There's been an explosion in autism and demand for behavioral therapies. The California Department of Insurance says insurers have been skirting their obligation under the state law requiring insurers to provide costly behavioral therapies for autism. The treatments can cost $50,000 a year for each child. The Los Angeles Times (http://lat.ms/XDRGFw ) says the agency is now proposing emergency regulations aimed at getting insurers to cover the treatments. The Office of Administrative Law will decide in March whether to put them into effect. State officials say they have received dozens of complaints that insurers have been delaying and denying coverage by imposing limits on how much therapy a child can receive and who can provide it. Information from: Los Angeles Times, http://www.latimes.com Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. See the rest here: Insurance commissioner wants autism law enforced … Continue reading

Comments Off on Insurance commissioner wants autism law enforced

Bill requiring insurance coverage for autism scrapped

Posted: Published on March 1st, 2013

A bill to mandate insurance coverage for autism treatment received a drastic makeover Thursday in the Utah Senate, disappointing hundreds of parents who hoped they could soon afford the necessary therapies for their children. In its original form, SB55 would have required insurance coverage for children diagnosed with autism spectrum disorder. About 18,000 such youth live in Utah, said the bills sponsor, Sen. Brian Shiozawa, R-Cottonwood Heights. Realizing the measure lacked the votes to pass either legislative chamber, Shiozawa pared it back Thursday, nixing the insurance and confining it to expansion of a pilot program enacted last year. He is asking to double participants to 500 and raise the age limit to seven. The current pilot program tops out at age six. "Its not my first choice," Shiozawa said of the substitute bill. "After conferring with House and Senate leadership I dont have the support of the insurance industry, and I frankly dont have the votes for the bill in its original form." The latest version of SB55 seeks $1.5 million in one-time funding to expand the pilot program, which Shiozawa believes would yield more accurate statistical data as a result. The original SB55 had estimated state budget costs at … Continue reading

Comments Off on Bill requiring insurance coverage for autism scrapped

Clogged heart arteries can foreshadow stroke

Posted: Published on March 1st, 2013

Feb. 28, 2013 Blockages in your heart arteries could mean you're more likely to have a stroke, even if you're considered low risk, according to research in the American Heart Association journal Stroke. "This study demonstrates that stroke risk is tightly aligned with coronary atherosclerosis, showing the closely related nature of cardiovascular and cerebrovascular disease," said Dirk M. Hermann, M.D., the study's lead investigator and professor of vascular neurology and dementia at the University Hospital Essen in Germany. "This raises the need for intensified interdisciplinary efforts for providing adequate disease prevention and management strategies." In the study, researchers used the non-invasive electron beam-computed tomography, a variation of the conventional CT scan, to determine how much plaque had built up in the coronary arteries of 4,180 patients who had no previous strokes or heart attacks. The patients, men and women 45-75 years old, were followed for about eight years. During the study, 92 strokes occurred. The blockages, caused by coronary artery calcification (CAC), were significantly higher in those who had a stroke than those who didn't. Those who had CAC levels of more than 400 Hounsfield units (HU), a density measurement, were three times more likely to have a stroke than … Continue reading

Comments Off on Clogged heart arteries can foreshadow stroke

After a stroke, every minute counts: New national guide for care

Posted: Published on March 1st, 2013

Feb. 28, 2013 From the moment a person starts to experience stroke symptoms, the clock starts ticking. Every minute that passes can make a difference in how well their brain, arms, legs, speech or thinking ability recover. Now, new national guidelines for stroke treatment -- co-authored by a member of the University of Michigan Comprehensive Stroke Program -- make it clear just how much minutes count. They also lay out a role for all types of hospitals in treating stroke emergencies, including community hospitals of the type involved in a recent U-M led study of stroke care. The American Stroke Association guidelines are published in the American Heart Association journal Stroke. The authors include Phillip Scott, M.D., a U-M emergency physician and member of the U-M Comprehensive Stroke Program. Here are some key numbers: Air medical transport and telemedicine support from large stroke-center hospitals such as U-M should be used to supplement the care any particular hospital can provide, the guidelines say. The new guidelines recommend integrating regional networks of comprehensive stroke centers (which offer 24/7, highly specialized treatment for all types of stroke); primary stroke centers (which provide 24/7 specialized care mainly for ischemic stroke); and acute stroke-ready hospitals … Continue reading

Comments Off on After a stroke, every minute counts: New national guide for care

Taking on Life One Step at a Time

Posted: Published on March 1st, 2013

BY Rebecca Levin February 28 - 2013 6:19 PM Anthony Purcell with his mother, Micki Walking: an action that, quite literally, keeps us moving. The task of walking seems quite simple: just put one foot in front of the other, thus becoming mobile. The ability to do so is taken for granted by most. That is, until that ability isn't so simple. It's what happened to Newport Beach resident Anthony Purcell. On a visit to Florida three years ago, then 19-year-old Purcell dove into the ocean, unaware of the dangerous sandbar that made shallow the water below. In an instant, Purcell broke several vertebrae, causing a severe spinal cord injury. The effects of paralysis were immediate as Purcells cousin pulled him out of the water and took him to the hospital, Purcells mother, Micki, close behind. Yet despite the bleak outlook, Micki and the Purcell family refused to give up. Effectively shunning paralysis as the prognosis, this family quickly banded together and began looking for treatment options. But the Purcell family had minimal time to construct a plan before Purcell was released from the hospital. A mere 20 days after his injury, Purcells insurance stopped funding the hospital stay and … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Taking on Life One Step at a Time

InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study

Posted: Published on March 1st, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced the Company has submitted an updated Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) requesting permission to begin human studies in order to test its biopolymer scaffolding for the treatment of acute SCI. The updated IDE submission is in response to exchanges since InVivos April 12, 2012 meeting with the FDA. The filing contains additional information regarding the manufacturing and pre-clinical testing of the scaffolding device. Once approved, the IDE will allow InVivo to conduct an open-label human study to collect safety and efficacy data to support FDA approval of the first in-cord treatment for SCI. The Company is also working with the FDA in order to have the scaffolding device designated as a Humanitarian Use Device (HUD), a designation that InVivo expects will create a faster path to market. We are prepared to safely treat acute SCI patients, and in the coming months we hope to have the first opportunity to translate to humans the positive effect from the scaffold that we observed in our 2008, 2009, and … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study

Parkinson's Disease Support Group members meet with Movement Disorder specialist

Posted: Published on March 1st, 2013

The Parkinsons Disease Support Group met Wednesday, Feb. 13, at the McGee Center with a very large group in attendance. Dr. Walter Lajara-Nanson, MD, was the special guest speaker. Dr. Lajara-Nanson is a Movement Disorder specialist from Bartlesville, Okla. The title of his presentation was Living Well With PD Understanding Parkinsons Disease and Current Treatments. Dr. Lajara-Nansons presentation covered a comprehensive overview of Parkinsons Disease from when Dr. James Parkinson first described it as a disease in 1817 to the present time with medicines, treatments, and research. The causes of PD are not known but experts believe it is a result of interaction between genetic and environmental causes. Parkinsons Disease is a chronic, progressive disease in which ordinary movement and other symptoms may worsen oven time. Dopamine produced in the brain helps control movement. When there is a loss of dopamine, it leads to difficulty controlling movement. At the present time, there are four PD medications: Levodopa which replaces dopamine; COMT inhibitors which preserve levodopa; Dopamine agonists which mimic dopamine; and MAO-B inhibitors which preserve existing dopamine. Dr. Lajara-Nanson encouraged those present to take their medicines as directed by their doctor as best they can as this helps the medicine … Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson's Disease Support Group members meet with Movement Disorder specialist

Amarantus BioScience to Present MANF Parkinson's Data at the 15th Annual American Society for Experimental …

Posted: Published on March 1st, 2013

SUNNYVALE, Calif., Feb. 28, 2013 /PRNewswire/ --Amarantus BioScience, Inc. (AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced that Dr. John W. Commissiong, Chief Scientific Officer, will be presenting data generated in six hydroxydopamine (6-OHDA) rodent models of Parkinson's disease at the 15th Annual Meeting of the American Society for Experimental NeuroTherapeutics (ASENT) in Washington, DC on March 1st, 2013. The meeting is being held February 28 March 2, 2013 at the Hyatt Regency in Bethesda, Maryland. "There is tremendous interest in our progress in Parkinson's disease research, and I look forward to meeting with leading researchers and industry professionals to discuss the important results we are seeing in our studies with MANF," said Dr. Commissiong. "ASENT is an outstanding forum to interact with colleagues, and stay apprised of the latest research in this field." About ASENT The American Society for Experimental NeuroTherapeutics is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance … Continue reading

Posted in Parkinson's Treatment | Comments Off on Amarantus BioScience to Present MANF Parkinson's Data at the 15th Annual American Society for Experimental …

TalkingTILES Taps into the Power of the Windows 8 Mobile Devices to Deliver a Breakthrough Level of Care in the …

Posted: Published on March 1st, 2013

OAKVILLE, ONTARIO--(Marketwire - Feb 28, 2013) - Editors Note: There is a photo associated with this press release. Mozzaz, an emerging leader in assistive technology and collaborative healthcare apps, further broadened its platform support today, announcing the availability of its Augmentative and Alternative Communication (AAC) app, TalkingTILES, for Microsoft Windows 8. The app is available for download through the Windows Store. "Since its launch in November, we''ve had a phenomenal response to TalkingTILES within the speech and language therapy and education markets, with thousands of downloads of the app in just the past month, as therapists, clients and caregivers embrace the opportunity to move collaboration in care into the mobile world," says Sammy Wahab, CEO of Mozzaz."Support for the Windows 8 environment is critical, as many of our customers are comfortable and familiar with applications built for the Windows desktop environment.Windows 8 is well suited to the demands of assistive technology, with the capability of delivering rich interactive apps alongside the power of Windows." "We run our Autism Centre on Windows PC''s and are increasingly using tablets as a therapeutic delivery tool, so we are extremely excited to be able to make a Windows 8 version of TalkingTILES available to … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on TalkingTILES Taps into the Power of the Windows 8 Mobile Devices to Deliver a Breakthrough Level of Care in the …

Page 5,634«..1020..5,6335,6345,6355,636..5,6405,650..»